Opening clinical trial data: Are the voluntary data-sharing portals enough?

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Geifman, Nophar ^a   Bollyky, Jennifer ^b   Bhattacharya, Sanchita ^a   Butte, Atul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical data; Clinical trials; Meta analysis; Open access; Reanalysis

Indexed keywords

ACCESS TO INFORMATION; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DATA SYNTHESIS; HUMAN; INFORMATION DISSEMINATION; INFORMATION RETRIEVAL; INFORMATION SEEKING; MEDICAL RESEARCH; NOTE; PUBLISHING; STANDARDIZATION; STUDY DESIGN; META ANALYSIS; METHODOLOGY; PROCEDURES; STATISTICAL ANALYSIS;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; RESEARCH DESIGN;

EID: 84946750927     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0525-y     Document Type: Note

References (6)

1. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington, DC: The National Academies Press; 2015.
2. Rosenblatt M, Jain SH, Cahill M. Sharing of clinical trial data: benefits, risks, and uniform principles. Ann Intern Med. 2015;162(4):306-7.
3. Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013;369(5):475-8.
4. Hede K. Project data sphere to make cancer clinical trial data publicly available. J Natl Cancer Inst. 2013;105(16):1159-60.
5. Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, Pontius J, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2-3):234-9.
6. Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30(11):2133-45.